HealthDay News — The US Food and Drug Administration (FDA) has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback